Fortress Biotech
FBIO
#10124
Rank
NZ$0.12 B
Marketcap
NZ$3.61
Share price
5.24%
Change (1 day)
-23.94%
Change (1 year)

Market capitalization of Fortress Biotech (FBIO)

Market cap: NZ$0.12 Billion

As of November 2026 Fortress Biotech has a market cap of NZ$0.12 Billion. This makes Fortress Biotech the world's 10124th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Fortress Biotech from 2011 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$0.12 B-39.91%
2025NZ$0.20 B73.51%
2024NZ$0.11 B63.68%
2023NZ$70.57 M-37.02%
2022NZ$0.11 B-69.27%
2021NZ$0.36 B-12.45%
2020NZ$0.41 B47.44%
2019NZ$0.28 B280.9%
2018NZ$74.16 M-73.94%
2017NZ$0.28 B49.39%
2016NZ$0.19 B-0.88%
2015NZ$0.19 B32.74%
2014NZ$0.14 B14.09%
2013NZ$0.12 B-5.13%
2012NZ$0.13 B-13.29%
2011NZ$0.15 B

End of Day market cap according to different sources

On Nov 10th, 2026 the market cap of Fortress Biotech was reported to be:

NZ$0.11 Billion
by Nasdaq info icon info icon
NZ$0.11 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Veracyte
VCYT
NZ$3.64 B 2,922.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
NZ$5.35 B 4,341.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Advaxis
ADXS.defunct
NZ$2.29 M-98.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Dynavax Technologies
DVAX
NZ$3.27 B 2,615.11%๐Ÿ‡บ๐Ÿ‡ธ USA